E-viri
PDF
Recenzirano
Odprti dostop
-
Chau, Nicole G.; Lorch, Jochen H.
The oncologist (Dayton, Ohio), July 2015, Letnik: 20, Številka: 7Journal Article
Targeted therapies have changed the landscape of cancer treatment, although they fail too many patients with advanced cancer. Still, insight gained from an exceptional responder has the power to identify new biomarkers of sensitivity that can unlock subsets of patients across anatomic disease sites who may also derive benefit and facilitate development of novel therapeutic strategies that may overcome resistance. The use of large‐scale genomic profiling is a promising first step.
